Signition LP’s Ironwood Pharmaceuticals IRWD Stock Holding History

Signition LP’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,664	Closed	-$100K	–	95
2019 Q3	$100K	Buy	+11,664	New	+$113K	0.4%	73

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Signition LP's IRWD Position: Q4 2019 in Review

Signition LP sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2019, closing a stake of 11,664 shares — an estimated $100K sold.

Signition LP first reported a position in IRWD in Q3 2019 and held it in 1 quarter. The position peaked at $100K in Q3 2019. 195 funds tracked by Wall St. Rank hold IRWD as of Q4 2019.

Signition LP reported no remaining Ironwood Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Signition LP sold 11,664 Ironwood Pharmaceuticals shares in Q4 2019, an estimated $100K.
Signition LP first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 1 quarter.
Signition LP's Ironwood Pharmaceuticals position peaked at $100K in Q3 2019.
195 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2019.

Based on Signition LP's 13F filing for Q4 2019, filed 3 Feb 2020.